Argullo, Baby Girl Ii B.
HRN: 24-70-64 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/25/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/25/2024
03/31/2024
IV
22mg
Q36h
Potentially Septic Newborn
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes